Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease

Future Microbiology

Volumn 9, Issue 3, 2014, Pages 361-377

  Uzal, Francisco A ^a   Freedman, John C ^b   Shrestha, Archana ^b   Theoret, James R ^b   Garcia, Jorge ^a   Awad, Milena M ^c   Adams, Vicki ^c   Moore, Robert J ^c,d   Rood, Julian I ^c   Mcclane, Bruce A ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c MONASH UNIVERSITY   (Australia)

^d CSIRO   (Australia)

Author keywords

animal disease; avian necrotic enteritis; Clostridium perfringens; enterocolitis; enterotoxemia; food poisoning; gas gangrene; human disease; toxins

Indexed keywords

CLOSTRIDIUM PERFRINGENS TOXIN; CLOSTRIDIUM TOXIN; ENTEROTOXIN; UNCLASSIFIED DRUG; BACTERIAL TOXIN;

ANIMAL DISEASE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BIRD DISEASE; CLINICAL FEATURE; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM PERFRINGENS INFECTION; DISEASES; FOOD POISONING; GAS GANGRENE; HUMAN; HUMAN DISEASE; INTESTINE INFECTION; NECROTIZING ENTERITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRAIN DIFFERENCE; ANIMAL; CLOSTRIDIUM INFECTION; INTESTINE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY;

ANIMAL DISEASES; ANIMALS; BACTERIAL TOXINS; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; GAS GANGRENE; HUMANS; INTESTINES;

EID: 84899497705     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.168     Document Type: Review

References (94)

1. McClane BA, Robertson SL, Li J. Clostridium perfringens. In: Food Microbiology: Fundamentals and Frontiers (4th Edition). Buchanan RL, Doyle MP (Eds). American Society for Microbiology, Washington, DC, USA, 465-489 (2013
2. McClane BA, Rood JI. Clostridial toxins involved in human enteric and histotoxic infections. In: Clostridia: Biotechnology and Medical Applications. Bahl H, Durre P (Eds). Wiley-VCH, Weinheim, Germany, 169-209 (2001
3. Grass JE, Gould LH, Mahon BE. Epidemiology of foodborne disease outbreaks caused by Clostridium perfringens, United States, 1998-2010. Foodborne Pathog. Dis. 10(2), 131-136 (2013
4. Scharff RL. Economic burden from health losses due to foodborne illness in the United States. J. Food. Protect. 75(1), 123-131 (2012
5. Carman RJ. Clostridium perfringens in spontaneous and antibiotic-Associated diarrhoea of man and other animals. Rev. Med. Microbiol. 8(Suppl. 1), S43-S45 (1997
6. McFarland LV. Diarrhoea associated with antibiotic use. BMJ 335(7610), 54-55 (2007
7. Keyburn AL, Bannam TL, Moore RJ, Rood JI. NetB, a pore-forming toxin from necrotic enteritis strains of Clostridium perfringens. Toxins 2(7), 1913-1927 (2010
8. Uzal FA, Vidal JE, McClane BA, Gurjar AA. Clostridium perfringens toxins involved in mammalian veterinary diseases. Open Toxinol. J. 3, 24-42 (2010
9. Stevens DL, Aldape MJ, Bryant AE. Life-Threatening clostridial infections. Anaerobe 18(2), 254-259 (2012
10. Shimizu T, Ohtani K, Hirakawa H et al. Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater. Proc. Natl Acad. Sci. USA 99(2), 996-1001 (2002
11. Myers GS, Rasko DA, Cheung JK et al. Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. Genome Res. 16(8), 1031-1040 (2006
12. Vidal JE, Chen J, Li J, McClane BA. Use of an EZ-Tn5-based random mutagenesis system to identify a novel toxin regulatory locus in Clostridium perfringens strain 13. PLoS ONE 4(7), e6232 (2009
13. Ohtani K, Yuan Y, Hassan S, Wang R, Wang Y, Shimizu T. Virulence gene regulation by the agr system in Clostridium perfringens. J. Bacteriol. 191(12), 3919-3927 (2009
14. Lyristis M, Bryant AE, Sloan J et al. Identification and molecular analysis of a locus that regulates extracellular toxin production in Clostridium perfringens. Mol. Microbiol. 12(5), 761-777 (1994
15. Shimizu T, Ba-Thein W, Tamaki M, Hayashi H. The virR gene, a member of a class of two-component response regulators, regulates the production of perfringolysin O, collagenase, and hemagglutinin in Clostridium perfringens. J. Bacteriol. 176(6), 1616-1623 (1994
16. Cheung JK, Low LY, Hiscox TJ, Rood JI. Regulation of extracellular toxin production in C. perfringens. In: Regulation of Bacterial Virulence. Vasil ML, Darwin AJ (Eds). American Society for Microbiology, Washington, DC, USA, 281-294 (2013
17. Shimizu T, Yaguchi H, Ohtani K, Banu S, Hayashi H. Clostridial VirR/VirS regulon involves a regulatory RNA molecule for expression of toxins. Mol. Microbiol. 43(1), 257-265 (2002
18. Oda M, Kabura M, Takagishi T et al. Clostridium perfringens alpha-Toxin recognizes the GM1a-TrkA complex. J. Biol. Chem. 287(39), 33070-33079 (2012
19. Heuck AP, Moe PC, Johnson BB. The cholesterol-dependent cytolysin family of Gram-positive bacterial toxins. Subcell. Biochem. 51, 551-577 (2010
20. Chiarot E, Faralla C, Chiappini N et al. Targeted amino acid substitutions impair streptolysin O toxicity and group A Streptococcus virulence. mBio. 4(1), e00387-12 (2013
21. Rossjohn J, Polekhina G, Feil SC, Morton CJ, Tweten RK, Parker MW. Structures of perfringolysin O suggest a pathway for activation of cholesterol-dependent cytolysins. J. Mol. Biol. 367(5), 1227-1236 (2007
22. Olofsson A, Hebert H, Thelestam M. The projection structure of perfringolysin O (Clostridium perfringens theta-Toxin). FEBS Lett. 319(1-2), 125-127 (1993
23. Awad MM, Bryant AE, Stevens DL, Rood JI. Virulence studies on chromosomal alpha-Toxin and theta-Toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-Toxin in Clostridium perfringens-mediated gas gangrene. Mol. Microbiol. 15(2), 191-202 (1995
24. Williamson ED, Titball RW. A genetically engineered vaccine against the alpha-Toxin of Clostridium perfringens protects mice against experimental gas gangrene. Vaccine 11(12), 1253-1258 (1993
25. O.Brien DK, Melville SB. Effects of Clostridium perfringens alpha-Toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues. Infect. Immun. 72(9), 5204-5215 (2004
26. Awad MM, Ellemor DM, Boyd RL, Emmins JJ, Rood JI. Synergistic effects of alpha-Toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene. Infect. Immun. 69(12), 7904-7910 (2001
27. Moe PC, Heuck AP. Phospholipid hydrolysis caused by Clostridium perfringens alpha-Toxin facilitates the targeting of perfringolysin O to membrane bilayers. Biochemistry 49(44), 9498-9507 (2010
28. Kennedy CL, Lyras D, Cheung JK, Hiscox TJ, Emmins JJ, Rood JI. Cross-complementation of Clostridium perfringens PLC and Clostridium septicum alpha-Toxin mutants reveals PLC is sufficient to mediate gas gangrene. Microb. Infect. 11(3), 413-418 (2009
29. Awad MM, Ellemor DM, Bryant AE et al. Construction and virulence testing of a collagenase mutant of Clostridium perfringens. Microb. Pathog. 28(2), 107-117 (2000
30. Chiarezza M, Lyras D, Pidot SJ et al. The NanI and NanJ sialidases of Clostridium perfringens are not essential for virulence. Infect. Immun. 77(10), 4421-4428 (2009
31. Chakravorty A, Awad MM, Hiscox TJ et al. The cysteine protease alpha-clostripain is not essential for the pathogenesis of Clostridium perfringens-mediated myonecrosis. PLoS ONE 6(7), e22762 (2011
32. Li J, Adams V, Bannam TL et al. Toxin plasmids of Clostridium perfringens. Microbiol. Mol. Biol. Rev. 77(2), 208-233 (2013
33. Deguchi A, Miyamoto K, Kuwahara T et al. Genetic characterization of type A enterotoxigenic Clostridium perfringens strains. PLoS ONE 4(5), e5598 (2009
34. Li J, McClane BA. A novel small acid soluble protein variant is important for spore resistance of most Clostridium perfringens food poisoning isolates. PLoS Pathog. 4(5), e1000056 (2008
35. Li J, Paredes-Sabja D, Sarker MR, McClane BA. Further characterization of Clostridium perfringens small acid soluble protein-4 (Ssp4) properties and expression. PLoS ONE 4(7), e6249 (2009
36. Shrestha A, McClane BA. Human claudin-8 and-14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin. mBio 4(1), pii: E00594-12 (2013
37. Robertson SL, Smedley JG 3rd, McClane BA. Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin. Infect. Immun. 78(1), 505-517 (2010
38. Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N. Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J. Cell. Biol. 136(6), 1239-1247 (1997
39. Angelow S, Ahlstrom R, Yu AS. Biology of claudins. Am. J. Physiol. Renal. 295(4), F867-F876 (2008
40. Briggs DC, Naylor CE, Smedley JG 3rd et al. Structure of the food-poisoning Clostridium perfringens enterotoxin reveals similarity to the aerolysin-like pore-forming toxins. J. Mol. Biol. 413(1), 138-149 (2011
41. Kitadokoro K, Nishimura K, Kamitani S et al. Crystal structure of Clostridium perfringens enterotoxin displays features of beta-pore-forming toxins. J. Biol. Chem. 286(22), 19549-19555 (2011
42. Smedley JG, 3rd, Saputo J, Parker JC et al. Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity. Infect. Immun. 76(8), 3793-3800 (2008
43. Caserta JA, Robertson SL, Saputo J, Shrestha A, McClane BA, Uzal FA. Development and application of a mouse intestinal loop model to study the in vivo action of Clostridium perfringens enterotoxin. Infect. Immun. 79(8), 3020-3027 (2011
44. Sarker MR, Carman RJ, McClane BA. Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops. Mol. Microbiol. 33(5), 946-958 (1999
45. Keyburn AL, Yan XX, Bannam TL, Van Immerseel F, Rood JI, Moore RJ. Association between avian necrotic enteritis and Clostridium perfringens strains expressing NetB toxin. BMC Vet. Res. 41(2), 21 (2010
46. Skinner JT, Bauer S, Young V, Pauling G, Wilson J. An economic analysis of the impact of subclinical (mild) necrotic enteritis in broiler chickens. Avian Dis. 54(4), 1237-1240 (2010
47. Cooper KK, Songer JG, Uzal FA. Diagnosing clostridial enteric disease in poultry. J. Vet. Diagn. Invest. 25(3), 314-327 (2013
48. Van Immerseel F, Rood JI, Moore RJ, Titball RW. Rethinking our understanding of the pathogenesis of necrotic enteritis in chickens. Trends. Microbiol. 17(1), 32-36 (2009
49. Keyburn AL, Boyce JD, Vaz P et al. NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens. PLoS Pathog. 4(2), e26 (2008
50. Yan XX, Porter CJ, Hardy SP et al. Structural and functional analysis of the pore-forming toxin NetB from Clostridium perfringens. mBio 4(1), e00019-13 (2013
51. Savva CG, Fernandes Da Costa SP, Bokori-Brown M et al. Molecular architecture and functional analysis of NetB, a pore-forming toxin from Clostridium perfringens. J. Biol. Chem. 288(5), 3512-3522 (2013
52. Cheung JK, Keyburn AL, Carter GP et al. The VirSR two-component signal transduction system regulates NetB toxin production in Clostridium perfringens. Infect. Immun. 78(7), 3064-3072 (2010
53. Allaart JG, De Bruijn ND, Van Asten AJ, Fabri TH, Grone A. NetB-producing and beta2-producing Clostridium perfringens associated with subclinical necrotic enteritis in laying hens in The Netherlands. Avian Pathol. 41(6), 541-546 (2012
54. Smyth JA, Martin TG. Disease producing capability of netB positive isolates of C. perfringens recovered from normal chickens and a cow, and netB positive and negative isolates from chickens with necrotic enteritis. Vet. Microbiol. 146(1-2), 76-84 (2010
55. Bannam TL, Yan XX, Harrison PF et al. Necrotic enteritis-derived Clostridium perfringens strain with three closely related independently conjugative toxin and antibiotic resistance plasmids. mBio 2(5), e00190-11 (2011
56. Lepp D, Gong J, Songer JG, Boerlin P, Parreira VR, Prescott JF. Identification of accessory genome regions in poultry Clostridium perfringens isolates carrying the netB plasmid. J. Bacteriol. 195(6), 1152-1166 (2013
57. Lepp D, Roxas B, Parreira VR et al. Identification of novel pathogenicity loci in Clostridium perfringens strains that cause avian necrotic enteritis. PLoS ONE 5(5), e10795 (2010
58. Jang S, Lillehoj H, Lee S. Vaccination with Clostridium perfringens recombinant proteins in combination with montanide TM ISA 71 adjuvant increases protection against experimental necrotic enteritis in commercial broiler chickens. Vaccine 30(36), 5401-5406 (2012
59. Keyburn AL, Portela RW, Sproat K et al. Vaccination with recombinant NetB toxin partially protects broiler chickens from necrotic enteritis. BMC Vet. Res. 44(1), 54 (2013
60. Fernandes Da Costa SP, Mot D, Bokori-Brown M et al. Protection against avian necrotic enteritis after immunisation with NetB genetic or formaldehyde toxoids. Vaccine 31(37), 4003-4008 (2013
61. Keyburn AL, Portela RW, Ford ME et al. Maternal immunization with vaccines containing recombinant NetB toxin partially protects progeny chickens from necrotic enteritis. BMC Vet. Res. 44(1), 108 (2013
62. Uzal FA, McClane BA. Recent progress in understanding the pathogenesis of Clostridium perfringens type C infections. Vet. Microbiol. 153(1-2), 37-43 (2011
63. Petrillo TM, Beck-Sague CM, Songer JG et al. Enteritis necroticans (pigbel) in a diabetic child. N. Engl. J. Med. 342(17), 1250-1253 (2000
64. Gui L, Subramony C, Fratkin J, Hughson MD. Fatal enteritis necroticans (pigbel) in a diabetic adult. Modern Pathol. 15(1), 66-70 (2002
65. Vidal JE, McClane BA, Saputo J, Parker J, Uzal FA. Effects of Clostridium perfringens beta-Toxin on the rabbit small intestine and colon. Infect. Immun. 76(10), 4396-4404 (2008
66. Fisher DJ, Fernandez-Miyakawa ME, Sayeed S et al. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model. Infect. Immun. 74(9), 5200-5210 (2006
67. Nagahama M, Hayashi S, Morimitsu S, Sakurai J. Biological activities and pore formation of Clostridium perfringens beta toxin in HL 60 cells. J. Biol. Chem. 278(38), 36934-36941 (2003
68. Autheman D, Wyder M, Popoff M, D.herde K, Christen S, Posthaus H. Clostridium perfringens beta-Toxin induces necrostatin-inhibitable, calpain-dependent necrosis in primary porcine endothelial cells. PLoS ONE 8(5), e64644 (2013
69. Miclard J, Jaggi M, Sutter E, Wyder M, Grabscheid B, Posthaus H. Clostridium perfringens beta-Toxin targets endothelial cells in necrotizing enteritis in piglets. Vet. Microbiol. 137(3-4), 320-325 (2009
70. Gurjar A, Li J, McClane BA. Characterization of toxin plasmids in Clostridium perfringens type C isolates. Infect. Immun. 78(11), 4860-4869 (2010
71. Sayeed S, Li J, McClane BA. Characterization of virulence plasmid diversity among Clostridium perfringens type B isolates. Infect. Immun. 78(1), 495-504 (2010
72. Vidal JE, Ma M, Saputo J, Garcia J, Uzal FA, McClane BA. Evidence that the Agr-like quorum sensing system regulates the toxin production, cytotoxicity and pathogenicity of Clostridium perfringens type C isolate CN3685. Mol. Microbiol. 83(1), 179-194 (2012
73. Ma M, Vidal J, Saputo J, McClane BA, Uzal F. The VirS/VirR two-component system regulates the anaerobic cytotoxicity, intestinal pathogenicity, and enterotoxemic lethality of Clostridium perfringens type C isolate CN3685. mBio 2(1), e00338-10 (2011
74. Uzal FA, Saputo J, Sayeed S et al. Development and application of new mouse models to study the pathogenesis of Clostridium perfringens type C Enterotoxemias. Infect. Immun. 77(12), 5291-5299 (2009
75. Garcia JP, Beingesser J, Fisher DJ et al. The effect of Clostridium perfringens type C strain CN3685 and its isogenic beta toxin null mutant in goats. Vet. Microbiol. 157(3-4), 412-419 (2012
76. Sayeed S, Uzal FA, Fisher DJ et al. Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model. Mol. Microbiol. 67(1), 15-30 (2008
77. Uzal FA, Songer JG. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J. Vet. Diagn. Invest. 20(3), 253-265 (2008
78. Chen J, Rood JI, McClane BA. Epsilon-Toxin production by Clostridium perfringens type D strain CN3718 is dependent upon the agr operon but not the VirS/VirR two-component regulatory system. mBio 2(6), (2011
79. Chen J, McClane BA. Role of the Agr-like quorum-sensing system in regulating toxin production by Clostridium perfringens type B strains CN1793 and CN1795. Infect. Immun. 80(9), 3008-3017 (2012
80. Popoff MR. Epsilon toxin: A fascinating pore-forming toxin. FEBS J. 278(23), 4602-4615 (2011
81. Hughes ML, Poon R, Adams V et al. Epsilon-Toxin plasmids of Clostridium perfringens type D are conjugative. J. Bacteriol. 189(21), 7531-7538 (2007
82. Sayeed S, Fernandez-Miyakawa ME, Fisher DJ et al. Epsilon-Toxin is required for most Clostridium perfringens type D vegetative culture supernatants to cause lethality in the mouse intravenous injection model. Infect. Immun. 73(11), 7413-7421 (2005
83. Garcia JP, Adams V, Beingesser J et al. Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheep, goats, and mice. Infect. Immun. 81(7), 2405-2414 (2013
84. Ma M, Li J, McClane BA. Genotypic and phenotypic characterization of Clostridium perfringens isolates from Darmbrand cases in post-World War II Germany. Infect. Immun. 80(12), 4354-4363 (2012
85. Fernandez-Miyakawa ME, Fisher DJ, Poon R et al. Both epsilon-Toxin and beta-Toxin are important for the lethal properties of Clostridium perfringens type B isolates in the mouse intravenous injection model. Infect. Immun. 75(3), 1443-1452 (2007
86. Guttenberg G, Hornei S, Jank T et al. Molecular characteristics of Clostridium perfringens TpeL toxin and consequences of mono-O-GlcNAcylation of Ras in living cells. J. Biol. Chem. 287(30), 24929-24940 (2012
87. Carter GP, Cheung JK, Larcombe S, Lyras D. Regulation of toxin production in the pathogenic clostridia. Mol. Microbiol. (2014) (In Press
88. Schrodinger L The PyMOL Molecular Graphics System (2008
89. Naylor C, Eaton J, Howells A et al. Structure of the key toxin in gas gangrene. Nat. Struct. Biol. 5, 738-746 (1998
90. Tsuge H, Nagahama M, Nishimura H et al. Crystal structure and site-directed mutagenesis of enzymatic components from Clostridium perfringens iota-Toxin. J. Mol. Biol. 325(3), 471-483 (2003
91. Rossjohn J, Feil SC, McKinstry WJ, Tweten RK, Parker MW. Structure of a cholesterol-binding, thiol-Activated cytolysin and a model of its membrane form. Cell 88, 685-692 (1997
92. Cole AR, Gibert M, Popoff M, Moss DS, Titball RW, Basak AK. Clostridium perfringens epsilon-Toxin shows structural similarity to the pore-forming toxin aerolysin. Nat. Struct. Biol. 11(8), 797-798 (2004
93. Huyet J, Naylor CE, Savva CG, Gibert M, Popoff MR, Basak AK. Structural Insights into delta toxin pore formation. PLoS ONE 8(6), e66673 (2013
94. Chen J, Ma M, Uzal FA, McClane BA. Host cell-induced signaling causes Clostridium perfringens to upregulate production of toxins important for intestinal infections. Gut Microbes 5, 1 (2013.